Management and board changes at Revotar
This article was originally published in Scrip
Revotar Biopharmaceuticals (Germany) has appointed Ludwig Felber chief financial officer and member of the executive board, and elected Professor Dr Wolfgang Hartwig as supervisory board member. Revotar's CEO, Dr Martin Pöhlchen, has also been appointed to the additional role of president. Mr Felber is the co-founder and former managing director of investment bank Viscardi. Professor Hartwig is managing director of Pharma R&D Consulting and the former global head of pharmaceutical R&D at Bayer HealthCare's pharmaceutical division.